repository
급성기 뇌경색 환자에서의 알부민 치료
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | 방오영 | - |
| dc.contributor.author | 신동훈 | - |
| dc.date.accessioned | 2019-10-21T06:48:23Z | - |
| dc.date.available | 2019-10-21T06:48:23Z | - |
| dc.date.issued | 2006-08 | - |
| dc.identifier.other | 1513 | - |
| dc.identifier.uri | https://dspace.ajou.ac.kr/handle/2018.oak/16946 | - |
| dc.description | 학위논문(석사)--아주대학교 일반대학원 :의학과,2006. 8 | - |
| dc.description.tableofcontents | TABLE OF CONTENTS ABSTRCT i TABLE OF CONTENTS ii LIST OF FIGURES iii LIST OF TABLES iv I. INTRODUCTION 1 II. MATERIALS AND METHODS 3 A. PATIENTS AND GROUPING 3 B. MEASUREMENTS 4 C. STATISTICAL ANALYSIS 6 III. RESULTS 7 IV. DISCUSSION 17 V. CONCLUSION 23 REFERENCES 24 국문요약 31 | - |
| dc.language.iso | eng | - |
| dc.publisher | The Graduate School, Ajou University | - |
| dc.rights | 아주대학교 논문은 저작권에 의해 보호받습니다. | - |
| dc.title | 급성기 뇌경색 환자에서의 알부민 치료 | - |
| dc.title.alternative | Dong Hoon Shin | - |
| dc.type | Thesis | - |
| dc.contributor.affiliation | 아주대학교 일반대학원 | - |
| dc.contributor.alternativeName | Dong Hoon Shin | - |
| dc.contributor.department | 일반대학원 의학과 | - |
| dc.date.awarded | 2006. 8 | - |
| dc.description.degree | Master | - |
| dc.identifier.localId | 565366 | - |
| dc.identifier.url | http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000001513 | - |
| dc.description.alternativeAbstract | - ABSTRCTS - Albumin Therapy in Acute Stroke Patient Preclinical studies have recently shown that albumin has neuroprotective effects for stroke in animal models. Thus, we sought to evaluate the effects of albumin therapy in patients with acute cerebral infarcts. We prospectively studied 49 patients with moderate-to-severe cerebral infarcts within the middle cerebral arterial territory into one of two groups: the control group (N=18) received saline, whereas the albumin group (N=31) received either 40 g or 80 g of albumin within 24 h from symptom onset. The National Institutes of Health Stroke Scale (NIHSS) and diffusion-weighted imaging (DWI) were serially checked. There was no adverse effect related to albumin therapy. Although there was no significant difference in both baseline NIHSS score and DWI lesion volume on admission, the NIHSS scores at the 14th day after treatment and the increase in DWI lesion volume 72？96 h after treatment were significantly reduced in patients of the albumin group (P=0.001 and 0.012, respectively); these effects were dose- and time-related. The outcome on the 90th day after stroke onset was more favorable in the albumin group than in the control group. However, among the albumin group, significant improvement was nearly exclusively observed in patients who had patent or recanalized vessels (P=0.004). Our results indicate that albumin therapy is a safe and effective modality in patients with acute cerebral infarction. This study also suggests that the effects of albumin therapy may vary depending on vessel status of the patient. | - |
- Appears in Collections:
- Graduate School of Ajou University > Department of Medicine > 3. Theses(Master)
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
- STATISTICS
- Total Visit :3,753,252
- Total Download :1,818
- Today View :30,910
